Cargando…

Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations

BACKGROUND: Hepatitis C virus (HCV) is a disease with a significant global impact, affecting approximately 2%-2.5% of the world’s population. New direct-acting antivirals (DAAs) have been introduced over the past few years with great success in viral eradication. The association of chronic HCV infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Kassas, Mohamed, Hegazy, Osama MO, Salah, Eman M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643207/ https://www.ncbi.nlm.nih.gov/pubmed/33200021 http://dx.doi.org/10.4254/wjh.v12.i10.841

Ejemplares similares

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
por: Salama, Iman Ibrahim, et al.
Publicado: (2022)

M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
por: Saleh, Shereen A, et al.
Publicado: (2020)

Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
por: Guardigni, Viola, et al.
Publicado: (2017)

Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
por: Abdulla, Maheeba, et al.
Publicado: (2022)

Bilateral simultaneous anterior ischemic optic neuropathy, an extrahepatic manifestation of hepatitis C cured with direct acting antivirals
por: Prud’homme, Sylvie, et al.
Publicado: (2016)

A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2021)

Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection
por: Hegab, Doaa Salah, et al.
Publicado: (2015)

Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
por: Fouad, Magdy, et al.
Publicado: (2021)

Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
por: Dybowska, Dorota, et al.
Publicado: (2023)

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review
por: El Kassas, Mohamed, et al.
Publicado: (2019)

Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
por: Nardelli, Silvia, et al.
Publicado: (2019)

Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
por: Damiani, Giovanni, et al.
Publicado: (2018)

Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
por: Chen, Jian-Hong, et al.
Publicado: (2017)

Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
por: Sun, Hsin-Yun, et al.
Publicado: (2022)

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Dermatologic Extrahepatic Manifestations of Hepatitis C
por: Dedania, Bhavtosh, et al.
Publicado: (2015)

Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China
por: Yang, Ying, et al.
Publicado: (2019)

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2022)

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
por: El Kassas, Mohamed, et al.
Publicado: (2019)

Extrahepatic manifestations in hepatitis C virus infection
por: Negro, Francesco, et al.
Publicado: (2017)

Extrahepatic manifestations of hepatitis E virus: An overview
por: Fousekis, Fotios S., et al.
Publicado: (2020)

New era for management of chronic hepatitis C virus using direct antiviral agents: A review
por: Elbaz, Tamer, et al.
Publicado: (2015)

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
por: Rupp, Christian, et al.
Publicado: (2018)

TT virus hepatitis with extrahepatic and hepatic manifestations - case report
por: Pântea, Victor, et al.
Publicado: (2013)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
por: Egmond, Elfi, et al.
Publicado: (2019)

Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study
por: Shousha, Hend Ibrahim, et al.
Publicado: (2021)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Fibrosis regression following hepatitis C antiviral therapy
por: Elsharkawy, Aisha, et al.
Publicado: (2022)

HCV Extrahepatic Manifestations
por: Kuna, Lucija, et al.
Publicado: (2019)

Prospective Comparison of Hepatocellular Carcinoma Behavior and Survival of Patients who Did or Did not Receive HCV Direct-Acting Antivirals
por: El-Kassas, Mohamed, et al.
Publicado: (2023)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
por: Ghweil, Ali A, et al.
Publicado: (2019)

Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
por: Tufan, Ayse Gokcen, et al.
Publicado: (2020)

Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Ramadan, Mohammad Said, et al.
Publicado: (2022)

The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
por: Dawood, Reham M, et al.
Publicado: (2022)

Extrahepatic Manifestations and Autoantibodies in Patients with Hepatitis C Virus Infection
por: Himoto, Takashi, et al.
Publicado: (2012)

Morphologic Features of Extrahepatic Manifestations of Hepatitis C Virus Infection
por: Ko, Huaibin M., et al.
Publicado: (2012)

A Rare Presentation of Hepatitis A Infection with Extrahepatic Manifestations
por: Bhatt, Geetika, et al.
Publicado: (2014)

Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
por: Voulgaris, Theodoros, et al.
Publicado: (2016)

Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection
por: Flores-Chávez, A., et al.
Publicado: (2017)

Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases
por: Callea, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p4bcnj3i9hbmh32blgum89fpel